reSee.it - Related Video Feed

Dr. Albert Bourla, Pfizer's chairman and CEO, is recognized for his significant impact on global COVID-19 response efforts. As a child of Holocaust survivors, Bourla led his team to develop a COVID-19 vaccine in record time, declining US federal funding to avoid bureaucracy and accelerate production. He is proud of his Jewish heritage, active in Holocaust remembrance, and a strong supporter of Israel, which was the first country outside the US to receive the Pfizer vaccine and antiviral pill. With over 2.5 billion Pfizer vaccine doses distributed, Bourla is credited with helping to save lives during the pandemic. For his contributions, Dr. Bourla has been selected as the recipient of the 2022 Genesis Prize, also known as the "Jewish Nobel Prize."

We are making this dream a reality with this announcement. The COVID vaccine has proven to be highly effective, although its logistics were complex due to the new technology.

We are ready to invest, as the president also mentioned, $70,000,000,000 in coming years from Pfizer in manufacturing and research in America alone. I would think this is an historical moment because I can put that behind us and focus on the things that I want to spend my time: cancer treatments, obesity medicines, vaccines, and things that people value. And thank you for allowing us to do that. I want to thank secretary Kennedy. I want to thank secretary Latnick. Your leadership helped us to pull that together. You are the masterminds of everything, and without the brilliant way that you designed the whole thing, we wouldn't be able to make it happen. We created trust from day one, and that was the most important thing that allowed us to pull very difficult negotiations. Mister president, thank you for your leadership and friendship. Albert, thank you. Great job.

Pfizer's CEO discusses the $43 billion acquisition of Cgen, highlighting the potential of Cgen's ADC technology in fighting cancer. The deal is expected to generate $10 billion in revenue by 2030, helping Pfizer reach its financial goals. The acquisition will provide revenue and cost synergies, similar to the success of mRNA technology. This move is seen as a low-risk, high-return opportunity for Pfizer.

On October 6, 2021, I met with my manager, Conwell Gill, a principal scientist at Pfizer. We discussed the ethics of giving people experimental booster shots for money. mRNA vaccines have been around for 50 years but never made it to clinical use due to side effects. Pfizer and Moderna used the emergency of the pandemic to push through their vaccines. Pfizer collaborated with Beyond Tech on mRNA technology for COVID-19. Everything was new and rushed due to the pandemic. There was no time to think, only to act.

In the fight against COVID-19, Pfizer CEO Dr. Albert Bourla, a child of Holocaust survivors, played a key role in developing the vaccine. His Jewish heritage and support for Israel are notable. Over 2.5 billion Pfizer vaccine doses have been distributed worldwide. For his contributions, Dr. Bourla received the 2022 Genesis Prize, known as the Jewish Nobel Prize. The pandemic continues, but Dr. Bourla's efforts have made a significant impact in saving lives globally.

Medicines we know from the COVID vaccine. Very effective, very welcome. The logistics around that vaccine were not straightforward because of the new technologies. We're talking about countries here that do not have advanced

We are taking precautions to protect our team members from COVID-19 to avoid any interruptions or wastage of vaccine doses. To ensure this, we are considering providing an additional batch of vaccines to our collaboration partners and team members. Regarding the vaccine mandate, Pfizer imported our Vaxa vaccine specifically for our employee vaccination program. This was done to ensure that no vaccines were taken from the European contingent.

Pfizer has had a terrible year, with its stock price cut in half and poor earnings. The big investors are selling millions of shares, indicating their lack of confidence. The CEO may not receive his bonus, but he still made $33 million last year. The interesting part is the connections between Pfizer's board members and other companies. One board member used to be the CEO of the Bill and Melinda Gates Foundation, while another was the former commissioner of the FDA. There is also a new company, Resilient, founded in 2020, with two Pfizer board members, the former FDA commissioner, and the CEO of In Q Tel. This raises suspicions, especially when combined with the struggling pharmaceutical industry. The speaker is curious if anyone else has investigated this matter.

Today in The Netherlands, outside the Court of Appeal in Amsterdam, a landmark case brings senior government officials, major media figures, pharmaceutical leadership, and global policy actors together as defendants in a single COVID response case. Among those ordered to appear are Albert Baller, the CEO of Pfizer, the former Dutch prime minister, senior Dutch health ministers, leading figures from the Dutch media, and Bill Gates. This makes the case extraordinary. On March 9, an important step is happening at the Amsterdam Court of Appeal. This hearing is not the main trial. The main trial is proceeding, and Bill Gates, if not appearing in person, must have representation and offer a defense. Today’s hearing concerns a procedural question: should the court allow an appeal against an earlier decision that blocked a request for preliminary evidence? In simple terms, the claimants ask the court for permission to present and examine expert evidence early before the trial, to have experts testify, documents examined, and key scientific and legal claims tested through cross examination. The lower court refused that request. The Amsterdam Court Of Appeal is being asked to decide whether that refusal should itself be reviewed. This hinges on the right to have evidence examined in public. If the appeal is allowed, expert testimony and scrutiny of the evidence could proceed; if refused, the claimants must continue without that preliminary examination. The reason for this hearing traces to the main lawsuit, begun in July 2023. Seven Dutch citizens filed a civil case in a district court, claiming they were misled about the nature of the COVID threat and about the safety and necessity of COVID vaccines. They argue that government officials, public health authorities, pharmaceutical executives, and major media figures promoted a narrative that induced fear and compliance based on unscientific claims of a novel pathogen called COVID nineteen. They claim these representations caused them to take vaccines and to suffer psychological and physical harm. The claimants describe a tort claim: the defendants breached a duty of care owed to the public by providing false or misleading information that resulted in damage. They seek two things: a declaration that the defendants acted unlawfully and compensation for the harm. Before the trial proceeds, the claimants asked for the evidence behind those claims to be examined in court, hence the provisional evidence request and today’s appeal. Central to the request are expert witnesses from multiple disciplines addressing scientific, legal, psychological, and institutional dimensions. The experts include Catherine Watt (legal researcher in public health law), Sasha Latipova (pharmaceutical regulatory processes), Doctor Joseph Sansone (psychologist studying crisis messaging and behavioral compliance), Catherine Austin Fitz (financial analyst on institutional power structures and global policy networks), and Doctor Mike Yeadon (English pharmacologist, former Pfizer VP). Yeadon has argued that the safety narrative surrounding the vaccines is challenged, claiming inadequate testing and concerns about toxicity. The point of a court is that such claims should be tested under cross examination, not dismissed without scrutiny. Allowing this appeal would enable the evidence to be heard and tested in public, with broader implications beyond the Netherlands, potentially influencing accountability, transparency, and public trust in other jurisdictions. What happens here may influence debates about open scrutiny of evidence in courts elsewhere. The speaker closes with a personal note, recalling six years spent fighting misinformation and supporting the truth be told campaign for COVID jabbed, injured, and bereaved, and underscoring that this case concerns justice in action, public scrutiny, and accountability for powerful institutions.

That extraordinary person is Pfizer Chairman and CEO, Doctor. Albert Borla. Doctor Borla led his team to deliver a COVID nineteen vaccine in record time while taking a risk by declining US federal funding to avoid government bureaucracy and expedite vaccine production. A child of Holocaust survivors from a Greek Jewish community destroyed by the Nazis, he's proud of his Jewish heritage, is active in Holocaust remembrance and education, and a strong supporter of Israel, which was the first country outside The US to receive the Pfizer vaccine and the antiviral pill. With more than two and a half billion Pfizer vaccine doses already distributed. Because of Doctor. Borla's extraordinary contribution to humanity as the world battles the worst health crisis in January, Doctor Albert Borla has been selected as the recipient of the 2022 Genesis Prize, the Jewish Nobel Prize. Thank you, and congratulations, Doctor. Borla.

I spoke with Pfizer's CEO, Albert Bourla, about the approval process. We discussed vaccine safety and serious side effects. Many companies and institutions are embracing the COVID vaccine due to its effectiveness. Logistics are crucial in this process. Translation (if needed): I talked to Pfizer's CEO, Albert Bourla, about the approval process. We talked about vaccine safety and serious side effects. Many companies and institutions are adopting the COVID vaccine because it works well. Logistics are important in this situation.

Can I please tell you this huge news? This is huge, you guys. Right. Right. Pfizer purchased a rival company called Arena Pharmaceuticals for $6,700,000,000, and what they do is they have drug products that treat immuno inflammatory diseases from injury. So Pfizer, who's giving the injuries, are now gonna be the solution. It's the The Fox watching the head house. Like, come on. This is what is a problem reaction solution? But now they're in charge of it all. They're in control of it all. That is the summary of the news.

Speaker 0: Calvin will receive one shot. We are leading in global vaccination efforts with over 1.1 billion shots administered. We will continue our efforts and have provided significant funding to ensure everyone can be vaccinated. It is crucial for us to play the largest role in vaccinating the world.

Speaker 0: My goal is to protect Israel and ensure its future. I want to be remembered as its protector. Speaker 1: Welcome, Mr. Prime Minister. Speaker 0: Thank you. Speaker 1: We convinced Pfizer that they could benefit from our data, and our health system distributed it efficiently through our digital system. I spoke with Pfizer's CEO 21 times, not 70. I also spoke with other company heads. Personal leadership is crucial in ensuring vaccine stock and distribution. Israel can serve as a global test case to understand the efficacy of vaccination in reopening economies. We are taking calculated risks to move forward and many countries can learn from us.

In the global fight against COVID-19, the Jewish people have had an outsized impact. As scientists, chief medical officers, and top healthcare officials, their contributions have been invaluable. However, one person stands above the rest: Pfizer Chairman and CEO, Dr. Albert Borla. I led my team to deliver a COVID-19 vaccine in record time, declining US federal funding to avoid bureaucracy and expedite production. As a child of Holocaust survivors, I am proud of my Jewish heritage and a strong supporter of Israel, the first country outside the US to receive the Pfizer vaccine and antiviral pill. The world is better off with my leadership in saving lives. With over 2.5 billion Pfizer vaccine doses distributed, I am honored to be selected as the recipient of the 2022 Genesis Prize, the Jewish Nobel Prize, for my contribution to humanity during the worst health crisis in a century.

We are ready to invest, as the president also mentioned, $70,000,000,000 in the next few years from Pfizer in manufacturing and research in America alone. I really think this is an historical moment because also I can put that behind us and focus on the things that I want to spend my time. Cancer treatments to bring better obesity medicines, to bring better vaccines, to bring things that people value. And thank you for allowing us to do that. I want to thank secretary Kennedy. I want to thank secretary Latnick. Your leadership helped us to pull that together. You are the mastermind of everything. But you are even more brilliant because you had someone in your team that he was the driving force behind everything.

Speaker 0: We need to investigate irregularities in their menstrual cycle, that’s number one, because that’s a little concerning and the reaction shouldn’t be interfering with that. Speaker 1: You’re a urologist, you must understand what’s going on with it. Speaker 0: It’s weird. I hope we don’t find out that there’s somehow this mRNA losing the body, because it has to be impacting something hormonal. It can impact menstrual cycles. The entire next generation is, like, super fucked up. Speaker 1: So tell me more, what’s developing with the mutation process? Speaker 0: They’re still conducting experiments, they’re optimizing it slowly, they’re very cautious and don’t want to accelerate too much. They’re doing it as exploratory work so you don’t advertise future mutations. Speaker 1: How would the research study be delayed for COVID stuff? Speaker 0: Now we’re focusing on mRNA beyond COVID. Our forward-looking studies must stay on track. Speaker 1: What is RNA going to be used for in the future? Speaker 0: Lots of stuff. Not just for viruses—we’re applying it to oncology, gene editing, and more. The portfolio has moved beyond COVID. There’s a dedicated COVID environment team; the company is asking where they’ll use this technology in the future for investors. Speaker 1: Is Pfizer going to be held liable for vaccine injuries? Speaker 0: I don’t think so. Usually drugs have known side effects. There have been reports like Clozapine being illegal, and Biox with heart issues—though that wasn’t for us, it was another company. They told me to monitor over time. So far, nothing major; we’ll see if anything arises. Speaker 1: Hope nobody grows three legs or the entire next generation is fucked up. Right? Speaker 0: Yeah. Or that their menstrual cycles are investigated down the line because that’s concerning. If you think about the science, it shouldn’t interact with the hypothalamic-pituitary-gonadal axis, which links hormones and menstrual cycles. It shouldn’t interfere—yet something might be happening. Speaker 1: The HPG axis. Speaker 0: It goes hypothalamus, pituitary, gonads—signal shingles. The HPG axis is tied to fertility problems. Speaker 1: They decide to pack these hormones somehow. But the signaling into the brain is tricky, and the vaccine doesn’t cross the blood-brain barrier. Speaker 0: If it does come down the line and something bad happens, there’d be substantial criticism given the social pressure and professional consequences. If downstream issues are really serious, the scale would be significant.

I found it very interesting to see the CEO of Pfizer, Albert Bourla, get booed at a White House Black History Month event after being introduced by Trump. Trump even seemed to anticipate the reaction. Pharmaceutical executives have become increasingly disliked, especially after the COVID vaccine situation. Bourla's presence seems to be part of an attempt to get the administration to be lenient on Pfizer, especially with RFK Junior now the Secretary of Health and Human Services. RFK Junior, a known vaccine skeptic, aims to address pharmaceutical company abuses. Bourla even had a secret dinner with RFK Junior to discuss chronic diseases. Despite this, Bourla believes there are still opportunities for Pfizer with the new administration. However, the public's negative reaction suggests a deep distrust and anger towards Pfizer, making it difficult for them to regain public confidence. We need to keep up the pressure to ensure accountability for their actions.

Vaccines generate significant profits for companies. Adding just one vaccine to the infant child schedule can result in $1 billion in annual sales. The widespread COVID-19 vaccination has been highly lucrative for Pfizer, earning them $54 billion in 1.5 years. Moderna, on the other hand, made $56 billion, while Moderna made $34 billion during the same period.

The speaker lists individuals in charge of the CDC, Pfizer, Moderna, BlackRock, and Johnson & Johnson, stating their dual citizenship with Israel and religion as Jewish. The speaker names Rochelle Walensky, Anne Shoalje, Sherry Berger, Mitchell Wolf, Jeff Rezzik, Jeff Zanes, Andy Slavitt, and Rachel Levine as holding positions in the CDC. Albert Bourla and Michael Dolsten are identified as being with Pfizer, and Paul Zaks with Moderna. Larry Fink and Rob Kapito are named as being with BlackRock, and Walt Schreiner and Michael Rosenwald with Johnson & Johnson.

I think it's fantastic that the same business that gave us Viagra, through the miracles of science and capitalism, has developed in record time a vaccine that solves one of the world's most pressing problems. Oh, you're kidding. Alright. Cook it. Well, look, I'll leave this and go back to the office. Yep. Bye. Bye. Positive case in in Auckland. Oh, I get it. So I think we better do a couple more things and then I gotta get up to

In late 2019, I first heard about a new virus in China. Initially, I thought it would be like SARS or MERS, but after attending Davos 2020, I realized it could be a pandemic. We are partnering with CP to develop a vaccine quickly, with the US government's help. SEPI is funding the project, and we aim to produce clinical-grade material for testing. This endeavor is unprecedented, and we are working together to achieve it. When the pandemic hit, we shifted focus to producing a billion doses. It's a challenging but necessary task.

We are ready to invest, as the president also mentioned, $70,000,000,000 in the next few years from Pfizer in manufacturing and research in America alone. I really think this is an historical moment because also I can put that behind us and focus on the things that I want to spend my time. I want to thank secretary Kennedy. I want to thank secretary Latnick. Your leadership helped us to pull that together. Of course, also, I want to to thank the US trade representative who is also heavily engaged, and he's probably the first trade representative that I have seen that cares about our industry and cares to do something about unfair situations out there, but more than anyone else. Mister president, I want to thank you Thank you very much. For your leadership and, frankly, for your friendship. Thank you. Albert, thank you very much. Great job.